Systematic review of miRNA as biomarkers in Alzheimer’s disease

Currently there are 850,000 people with Alzheimer’s disease in the UK, with an estimated rise to 1.1 million by 2025. Alzheimer’s disease is characterised by the accumulation of amyloid-beta plaques and hyperphosphorylated tau in the brain causing a progressive decline in cognitive impairment. Small...

Full description

Saved in:
Bibliographic Details
Main Authors: Samantha Swarbrick, Nick Wragg, Sourav Ghosh, Alexandra Stolzing
Format: Default Article
Published: 2019
Subjects:
Mechanical engineering not elsewhere classified
miRNA
Alzheimer disease
Biomarkers
Brain
Peripheral blood
Mechanical Engineering not elsewhere classified
Online Access:https://hdl.handle.net/2134/37084
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://hdl.handle.net/2134/37084

Similar Items